Telomir-1 reverses cellular decline markers in human cell lines; supports autism and spasmodic dysphonia programs

Telomir Pharmaceuticals, Inc.

New preclinical data show Telomir-1 improved cell viability under stress and boosted mitochondrial function in human cell lines.
Telomir-1 reduced reactive oxygen species (ROS) and restored calcium signaling, limiting oxidative damage and maintaining cellular communication.
Telomir-1 protected cells from iron- and copper-induced toxicity, which are linked to ROS formation and accelerated aging.
Findings provide mechanistic foundation for new research initiatives in autism spectrum disorder (ASD) and spasmodic dysphonia (SD).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.